{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:03:58Z","timestamp":1778511838270,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clml.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T11:50:37Z","timestamp":1573127437000},"page":"e270-e283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-2984","authenticated-orcid":false,"given":"Yuting","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0448-7210","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.11.002_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.42.6.567","article-title":"Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group","volume":"42","author":"Bennett","year":"1989","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clml.2019.11.002_bib2","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"158","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.clml.2019.11.002_bib3","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2016.160374","article-title":"Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier","volume":"102","author":"Navarro","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2019.11.002_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hon.2461","article-title":"Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: a single-centre analysis","volume":"36","author":"Miao","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2019.11.002_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.leu.2402737","article-title":"Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias","volume":"17","author":"Cro","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.11.002_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/asheducation-2017.1.338","article-title":"Optimizing frontline therapy of CLL based on clinical and\u00a0biological factors","volume":"2017","author":"Fischer","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2019.11.002_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma\u2014a spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clml.2019.11.002_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2019.11.002_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A\u00a0new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.002_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/10428194.2010.531411","article-title":"TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia","volume":"52","author":"Yi","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.11.002_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","article-title":"Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)","volume":"108","author":"Moreau","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.11.002_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bjh.14901","article-title":"Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200","volume":"179","author":"Kohnke","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.11.002_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","article-title":"Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification","volume":"138","author":"Sun","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.11.002_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-6-77","article-title":"Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution","volume":"6","author":"Yang","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.clml.2019.11.002_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12185-013-1432-7","article-title":"Multiparameter flow cytometry is necessary for detection, characterization and diagnostics of composite mature B-cell lymphoproliferative neoplasms","volume":"98","author":"Perkovic","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2019.11.002_bib16","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1182\/blood-2011-02-334326","article-title":"Differential and tumor-specific expression of CD160 in B-cell malignancies","volume":"118","author":"Farren","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.002_bib17","first-page":"1171","article-title":"Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004","volume":"19","author":"Carreon","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2019.11.002_bib18","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.18632\/oncotarget.3101","article-title":"Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans","volume":"6","author":"Xia","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2019.11.002_bib19","doi-asserted-by":"crossref","first-page":"20520","DOI":"10.18632\/oncotarget.7819","article-title":"Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia","volume":"7","author":"Marinelli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2019.11.002_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2019.11.002_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Chihara","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.11.002_bib22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.002_bib23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/bjh.13498","article-title":"Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort","volume":"170","author":"Davids","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.11.002_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2014-02-556399","article-title":"Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia","volume":"124","author":"Pflug","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.002_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2011-08-368209","article-title":"The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms","volume":"119","author":"Arcaini","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.002_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1309\/AJCP10ZCLFZGYZIP","article-title":"MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders","volume":"140","author":"Ondrejka","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.11.002_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2019.11.002_bib28","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2019.11.002_bib29","first-page":"113","article-title":"Splenic marginal zone lymphomas with peripheral CD5 expression","volume":"89","author":"Giannouli","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2019.11.002_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1309\/AJCPKUM9J4IXCWEU","article-title":"Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders","volume":"136","author":"Venkataraman","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.11.002_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ajcp\/aqx041","article-title":"Flow cytometric patterns of CD200 and CD1d expression distinguish CD10-negative, CD5-negative mature B-cell lymphoproliferative disorders","volume":"148","author":"Mason","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.11.002_bib32","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.3109\/10428194.2015.1030642","article-title":"Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis","volume":"56","author":"Fan","year":"2015","journal-title":"Leuk Lymphoma"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019320993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019320993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:33:43Z","timestamp":1761870823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265019320993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2152265019320993"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.11.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}